Company intelligence / Profile preview

BinomixRay

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Binomix (Beijing Binomix Technology) is a biotechnology company specializing in high-throughput single-cell sequencing and spatial transcriptomics. The company provides comprehensive solutions for life science research, including sample preparation, sequencing services, and advanced bioinformatics analysis. Their platform is designed to decode cellular heterogeneity and spatial organization in complex biological systems, supporting applications in oncology, immunology, and developmental biology. Binomix focuses on delivering high-resolution genomic data to accelerate drug discovery and clinical research.

Modalities: Single-cell sequencingSpatial transcriptomics
Industry: Drug Discovery Services

Beyond the preview

Go deeper on BinomixRay.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BinomixRay.

Explore the full profile